News

This is done while maintaining a favorable safety and tolerability profile in the patients, according to the study published in The New England Journal of Medicine. Vita-Salute San

HS is a difficult-to-treat, chronic, inflammatory skin disease characterized by painful, recurrent abscesses, and nodules that primarily appear in the groin or under the armpits or breasts and

Mylan-Rosuvastatin is the generic version of Astra Zeneca’s Crestor Tablets, which are used for the management of primary hypercholesterolaemia, mixed dyslipidaemia, and familial hypercholesterolaemia. Rosuvastatin Calcium Tablets, 5mg,

TH-302 is a hypoxia-targeted drug where as Bortezomib is approved for the treatment of multiple myeloma, a hematologic cancer that develops in the bone marrow. The primary objectives

The new database is expected to enable the pharmaceutical company to deliver improved stakeholder understanding and relationship-building, and to gain access to the solution’s full panel of European

As per the agreement signed in the first quarter of 2012, the global health brand will deploy the CallidusCloud solutions with the company Salesforce.com CRM solution to drive

The randomized double-blind placebo-controlled multi-center Phase II clinical trial enrolled a total of 164 patients to investigate the efficacy and safety of Trimesta. Synthetic Biologics chief executive officer

The study will evaluate the safety and immunogenicity of ONT-10 in patients with cancers which commonly express MUC1, such as breast, non-small cell lung, ovarian, colorectal, prostate, pancreatic,

The company received FDA approval for Natazia in May 2010 for the prevention of pregnancy. The contraceptive efficacy of Natazia has not been evaluated in women with a